Olympus KK
7733
ISIN JP3201200007 / Valor 763197
Olympus KK
UMushroom community rating:
About company
Olympus KK is a global medical technology company specializing in endoscopic and therapeutic solutions. The company leverages its expertise in medical technology, therapeutic intervention, and precision manufacturing to provide healthcare professionals with tools for diagnostic, therapeutic, and minimally invasive procedures. Olympus' Endoscopic Solutions portfolio includes endoscopes, laparoscopes, video imaging systems, and system integration solutions, while its Therapeutic Solutions portfolio features surgical energy devices and various instruments aimed at disease prevention, detection, and treatment. With a history dating back to the introduction of the first gastrocamera in 1950 and the development of the polypectomy snare, Olympus continues to innovate in order to improve clinical outcomes, reduce healthcare costs, and enhance patient safety and quality of life.
Summarized from source with an LLMView SourceSector: Consumer Non-CyclicalsLatest Results (14.08.2024):
Revenue Growth
Olympus KK reported a revenue of ¥675,714 million for the nine months ending December 31, 2023, marking a 5.3% increase from the same period in the previous fiscal year. This growth reflects the company's strong performance in its continuing operations.
Operating Profit Decline
The operating profit for Olympus KK during the nine months ending December 31, 2023, was ¥39,035 million, which represents a significant decline of 72.6% compared to the same period last year. This decrease is attributed to various operational challenges faced by the company.
Profit Before Tax
For the nine months ending December 31, 2023, Olympus KK's profit before tax stood at ¥110,172 million, showing a 14.0% decrease from the previous year. This decline is part of the broader trend of reduced profitability observed in the company's financial results.
Basic Earnings Per Share
Olympus KK reported basic earnings per share of ¥191.59 for the nine months ending December 31, 2023, which is a substantial increase of 87.7% compared to the same period in the previous fiscal year. This rise in earnings per share is a positive indicator for shareholders.
Dividends Forecast
Olympus KK has forecasted an annual dividend of ¥18.00 per share for the fiscal year ending March 31, 2024. This is an increase from the ¥16.00 per share dividend paid in the previous fiscal year, reflecting the company's commitment to returning value to its shareholders.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
18858 M
Market cap (USD)
3,384,300
Daily traded volume (Shares)
2515.5 / 2463.5
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
J V
Laura Bischofberger
Lea Katunaric
EQUITIES OF THE SAME SECTOR
